Report Published: "Cambodia Pharmaceuticals & Healthcare Report Q2 2013"
BMI View: Cambodia is a market with strong growth potential for pharmaceutical firms, given the many unmet medical needs. However, we highlight that such frontier markets are highly risky, given the lack of proper regulation, extensive bureaucracy and rampant corruption. As a consequence, firms looking to expand in these regions must contend with low or negative sales growth initially.
View full press release